Filter the drugs by their status, phase of research and how they help

COVID-19 is respiratory dissease caused by SARS-CoV-2 virus. Browse the database of drugs treating specific mutations compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Thearubigin Potential treatment - theoretical effect Natural product Antiviral Aug/04/2020 Aug/12/2020 0
Camellia sinensis extract Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020 Aug/12/2020 0
Terminalia chebula extract Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020 Aug/12/2020 0
Herbacetin Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020 Aug/12/2020 0
Pectolinarin Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020 Aug/12/2020 0
Baicalin Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020 Aug/12/2020 0
Galuteolin Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020 Aug/12/2020 0
Quercitrin Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020 Aug/12/2020 0
Myricitrin Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020 Aug/12/2020 0
Icariin Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020 Aug/12/2020 0